目的研究FOCUS超声刀在胸大肌肌皮瓣(pectoralis major myocutaneous flap,PMMF)制备中的优势及技术要点。方法 2009年1月至2011年6月共采用FOCUS超声刀制备PMMF 16例,以2007年6月至2008年12月采用传统手术方法制备PMMF的15例为对照组,...目的研究FOCUS超声刀在胸大肌肌皮瓣(pectoralis major myocutaneous flap,PMMF)制备中的优势及技术要点。方法 2009年1月至2011年6月共采用FOCUS超声刀制备PMMF 16例,以2007年6月至2008年12月采用传统手术方法制备PMMF的15例为对照组,比较两组的肌皮瓣制备时间、术中出血量、术后引流量、皮瓣成功率和供区并发症等指标。结果超声刀组与传统手术组相比,肌皮瓣平均制备时间短[(44.8±8.3)min vs. (57.7±6.8)min,P=0.000],术中出血量少[(39.4±13.4)mL vs.(65.3±19.9)mL,P=0.000],术后引流量相近[(110.6±28.9)mL vs.(138.0±48.0)mL,P=0.599],分别有1例和2例发生皮瓣部分坏死,两组皮瓣存活率相近(87.5% vs. 86.7%,P=0.600)。两组均无术后出血和切口感染等供区并发症。结论采用FOCUS超声刀制备PMMF较传统手术时间短,出血少,手术创伤小,有利于患者的恢复。展开更多
Objective: To analyze the patterns of relapse and management options in unknown primary cervical metastatic carcinoma (UPCMC) as well as to discuss its treatment strategies. Methods: Clinical data of 111 cases of elig...Objective: To analyze the patterns of relapse and management options in unknown primary cervical metastatic carcinoma (UPCMC) as well as to discuss its treatment strategies. Methods: Clinical data of 111 cases of eligible UPCMC were retrospectively studied. Neck control, primary relapse and long-term survival were compared among different groups. Results: Primary carcinomas ultimately appeared in 12 cases (10.8%, 12/111). Neck control rate was 36.9%. Overall 5-year survival rate was 41.4%. Neck control, N stage and primary control were prognostic factors for UPCMC. Neck control was affected by N stage and whether or not comprehensive radiotherapy was administered. Conclusion: UPCMC should primarily be treated by radiotherapy except for cases with N1 or N2 insensitive to radiation. Bilateral necks radiotherapy is the optimal choice in terms of neck radiotherapy. Selective total pharyngeal irradiation is recommended for potential primary treatment.展开更多
文摘目的研究FOCUS超声刀在胸大肌肌皮瓣(pectoralis major myocutaneous flap,PMMF)制备中的优势及技术要点。方法 2009年1月至2011年6月共采用FOCUS超声刀制备PMMF 16例,以2007年6月至2008年12月采用传统手术方法制备PMMF的15例为对照组,比较两组的肌皮瓣制备时间、术中出血量、术后引流量、皮瓣成功率和供区并发症等指标。结果超声刀组与传统手术组相比,肌皮瓣平均制备时间短[(44.8±8.3)min vs. (57.7±6.8)min,P=0.000],术中出血量少[(39.4±13.4)mL vs.(65.3±19.9)mL,P=0.000],术后引流量相近[(110.6±28.9)mL vs.(138.0±48.0)mL,P=0.599],分别有1例和2例发生皮瓣部分坏死,两组皮瓣存活率相近(87.5% vs. 86.7%,P=0.600)。两组均无术后出血和切口感染等供区并发症。结论采用FOCUS超声刀制备PMMF较传统手术时间短,出血少,手术创伤小,有利于患者的恢复。
文摘Objective: To analyze the patterns of relapse and management options in unknown primary cervical metastatic carcinoma (UPCMC) as well as to discuss its treatment strategies. Methods: Clinical data of 111 cases of eligible UPCMC were retrospectively studied. Neck control, primary relapse and long-term survival were compared among different groups. Results: Primary carcinomas ultimately appeared in 12 cases (10.8%, 12/111). Neck control rate was 36.9%. Overall 5-year survival rate was 41.4%. Neck control, N stage and primary control were prognostic factors for UPCMC. Neck control was affected by N stage and whether or not comprehensive radiotherapy was administered. Conclusion: UPCMC should primarily be treated by radiotherapy except for cases with N1 or N2 insensitive to radiation. Bilateral necks radiotherapy is the optimal choice in terms of neck radiotherapy. Selective total pharyngeal irradiation is recommended for potential primary treatment.
